Author

Emi A. Lutz

Massachusetts Institute of TechnologyORCID 0000-0002-7649-4241Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Adityanarayanan RadhakrishnaniD· 1 shared Alexander MeissneriD· 1 shared Duncan M. MorganiD· 1 shared Eric S. LanderiD· 1 shared Fiona ChatterjeeiD· 1 shared Jain Yajit· 1 shared John Christopher LoveiD· 1 shared Karl Dane WittrupiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adityanarayanan RadhakrishnanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PD-1 blockade during T cell priming enhances long-term protection against metastatic tumors by epigenetically tuning T cell exhaustion

Teresa Dinter, Sebastian D. Mackowiak, Zachary J. Rogers, Vidit Bhandarkar, Molly Y. Carney, Yiming J. Zhang, Duncan M. Morgan, Lorelai Pop, Fiona Chatterjee, Emi A. Lutz, Jain Yajit, Adityanarayanan Radhakrishnan, Eric S. Lander, Karl Dane Wittrup, John Christopher Love, , Stefani Spranger

This study shows PD-1 blockade during T cell priming promotes an intermediate-exhausted CD8 T cell state that supports durable anti-tumor immunity after surgery and metastatic challenge, better than effector or memory-like T cells.

bioRxiv · Nov 25, 2025 · PreprintImmunology